#news #biotech Real-world evidence platform developer Aetion nabs Amgen-backed $36M series B

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Real-world evidence platform developer Aetion nabs Amgen-backed $36M series B .Venture capitalists have noticed the biopharma industry’s growing interest in real-world evidence spurred by the Cures Act, and they are putting big money behind a firm that develops a software just for that practice.

from FierceBiotech: Biotech https://ift.tt/2v3Vnxy